Deinove (XPAR:ALDEI) Total Assets : €6.01 Mil (As of Jun. 2022)

View and export this data going back to 2010. Start your Free Trial

What is Deinove Total Assets?

Deinove's Total Assets for the quarter that ended in Jun. 2022 was €6.01 Mil.

Total Assets is connected with ROA %. Deinove's annualized ROA % for the quarter that ended in Jun. 2022 was -92.51%. Total Assets is also linked to Revenue through Asset Turnover. Deinove's Asset Turnover for the quarter that ended in Jun. 2022 was 0.02.

Deinove Total Assets Historical Data

The historical data trend for Deinove's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deinove Total Assets Chart

Deinove Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Assets

Get a 7-Day Free Trial

14.14

16.62

10.39

9.41

9.38

Deinove Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Total Assets	Get a 7-Day Free Trial															10.11	9.41	9.09	9.38	6.01

Deinove Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Deinove's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets	=	Total Equity (A: Dec. 2021 )	+	Total Liabilities (A: Dec. 2021 )
	=	-13.031	+	22.408
	=	9.38

Deinove's Total Assets for the quarter that ended in Jun. 2022 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2022 )	+	Total Liabilities (Q: Jun. 2022 )
	=	-15.475	+	21.486
	=	6.01

Deinove (XPAR:ALDEI) Total Assets Explanation

Total Assets is connected with ROA %.

Deinove's annualized ROA % for the quarter that ended in Jun. 2022 is

ROA %	=	Net Income (Q: Jun. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Jun. 2022 ))	/ count )
	=	-7.118	/	( (9.377	+	6.011)	/ 2 )
	=	-7.118	/	7.694
	=	-92.51 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Deinove's Asset Turnover for the quarter that ended in Jun. 2022 is

	Asset Turnover
=	Revenue (Q: Jun. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Jun. 2022 ))	/ count )
=	0.124	/	( (9.377	+	6.011)	/ 2 )
=	0.124	/	7.694
=	0.02

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Deinove Total Assets Related Terms

Thank you for viewing the detailed overview of Deinove's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Deinove (XPAR:ALDEI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Deinove SA (XPAR:ALDEI) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1682 rue de la Valsiere, Cap Sigma, ZAC Euromedecine II, Grabels, FRA, 34790

Website

http://www.deinove.com

Deinove SA is a biotechnology company engaged in the development of technologies and molecules for the health, nutrition and cosmetics industries. It is developing in two areas of activity, New-generation anti-infective ANTIBIOTICS which involves the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the challenges of antibiotic resistance; and BIOACTIVES, natural active ingredients discovers, develops and produces bioactives, active ingredients of natural origin from its bacterial biodiversity bank, to invent the new generation of sustainable cosmetics and intends to quickly bring its know-how and its products to other fields, such as nutrition and health.

Deinove (XPAR:ALDEI) Headlines

No Headlines